| Sr. No. | Cat No. | Product Description | Pack Size |
|---|---|---|---|
| 3001 | ICH5283-20mg | Varokibart Biosimilar – Research Grade | 20mg |
| 3002 | ICH5283-50mg | Varokibart Biosimilar – Research Grade | 50mg |
| 3003 | ICH5283-5mg | Varokibart Biosimilar – Research Grade | 5mg |
| 3004 | ICH5284-10mg | Vilamakitug Biosimilar – Research Grade | 10mg |
| 3005 | ICH5284-1mg | Vilamakitug Biosimilar – Research Grade | 1mg |
| 3006 | ICH5284-20mg | Vilamakitug Biosimilar – Research Grade | 20mg |
| 3007 | ICH5284-50mg | Vilamakitug Biosimilar – Research Grade | 50mg |
| 3008 | ICH5284-5mg | Vilamakitug Biosimilar – Research Grade | 5mg |
| 3009 | ICH5285-10mg | Vilobelimab Biosimilar – Research Grade | 10mg |
| 3010 | ICH5285-1mg | Vilobelimab Biosimilar – Research Grade | 1mg |
| 3011 | ICH5285-20mg | Vilobelimab Biosimilar – Research Grade | 20mg |
| 3012 | ICH5285-50mg | Vilobelimab Biosimilar – Research Grade | 50mg |
| 3013 | ICH5285-5mg | Vilobelimab Biosimilar – Research Grade | 5mg |
| 3014 | ICH5286-10mg | Visugromab Biosimilar – Research Grade | 10mg |
| 3015 | ICH5286-1mg | Visugromab Biosimilar – Research Grade | 1mg |
| 3016 | ICH5286-20mg | Visugromab Biosimilar – Research Grade | 20mg |
| 3017 | ICH5286-50mg | Visugromab Biosimilar – Research Grade | 50mg |
| 3018 | ICH5286-5mg | Visugromab Biosimilar – Research Grade | 5mg |
| 3019 | ICH5287-10mg | Volociximab Biosimilar – Research Grade | 10mg |
| 3020 | ICH5287-1mg | Volociximab Biosimilar – Research Grade | 1mg |
| 3021 | ICH5287-20mg | Volociximab Biosimilar – Research Grade | 20mg |
| 3022 | ICH5287-50mg | Volociximab Biosimilar – Research Grade | 50mg |
| 3023 | ICH5287-5mg | Volociximab Biosimilar – Research Grade | 5mg |
| 3024 | ICH5288-10mg | Vonsetamig Biosimilar – Research Grade | 10mg |
| 3025 | ICH5288-1mg | Vonsetamig Biosimilar – Research Grade | 1mg |
| 3026 | ICH5288-20mg | Vonsetamig Biosimilar – Research Grade | 20mg |
| 3027 | ICH5288-50mg | Vonsetamig Biosimilar – Research Grade | 50mg |
| 3028 | ICH5288-5mg | Vonsetamig Biosimilar – Research Grade | 5mg |
| 3029 | ICH5289-10mg | Xeligekimab Biosimilar – Research Grade | 10mg |
| 3030 | ICH5289-1mg | Xeligekimab Biosimilar – Research Grade | 1mg |
| 3031 | ICH5289-20mg | Xeligekimab Biosimilar – Research Grade | 20mg |
| 3032 | ICH5289-50mg | Xeligekimab Biosimilar – Research Grade | 50mg |
| 3033 | ICH5289-5mg | Xeligekimab Biosimilar – Research Grade | 5mg |
| 3034 | ICH5290-10mg | Zansecimab Biosimilar – Research Grade | 10mg |
| 3035 | ICH5290-1mg | Zansecimab Biosimilar – Research Grade | 1mg |
| 3036 | ICH5290-20mg | Zansecimab Biosimilar – Research Grade | 20mg |
| 3037 | ICH5290-50mg | Zansecimab Biosimilar – Research Grade | 50mg |
| 3038 | ICH5290-5mg | Zansecimab Biosimilar – Research Grade | 5mg |
| 3039 | ICH5291-10mg | Zigakibart Biosimilar – Research Grade | 10mg |
| 3040 | ICH5291-1mg | Zigakibart Biosimilar – Research Grade | 1mg |
| 3041 | ICH5291-20mg | Zigakibart Biosimilar – Research Grade | 20mg |
| 3042 | ICH5291-50mg | Zigakibart Biosimilar – Research Grade | 50mg |
| 3043 | ICH5291-5mg | Zigakibart Biosimilar – Research Grade | 5mg |
| 3044 | ICH5292-10mg | Zimberelimab Biosimilar – Research Grade | 10mg |
| 3045 | ICH5292-1mg | Zimberelimab Biosimilar – Research Grade | 1mg |
| 3046 | ICH5292-20mg | Zimberelimab Biosimilar – Research Grade | 20mg |
| 3047 | ICH5292-50mg | Zimberelimab Biosimilar – Research Grade | 50mg |
| 3048 | ICH5292-5mg | Zimberelimab Biosimilar – Research Grade | 5mg |
| 3049 | ICH5293-100mg | Tisotumab Biosimilar – Research Grade | 100mg |
| 3050 | ICH5293-10mg | Tisotumab Biosimilar – Research Grade | 10mg |
| 3051 | ICH5293-20mg | Tisotumab Biosimilar – Research Grade | 20mg |
| 3052 | ICH5293-50mg | Tisotumab Biosimilar – Research Grade | 50mg |
| 3053 | ICH5293-5mg | Tisotumab Biosimilar – Research Grade | 5mg |
| 3054 | ICH5293-1mg | Tisotumab Biosimilar – Research Grade | 1mg |
| 3055 | ICH5294-100mg | Depatuxizumab Biosimilar – Research Grade | 100mg |
| 3056 | ICH5294-10mg | Depatuxizumab Biosimilar – Research Grade | 10mg |
| 3057 | ICH5294-20mg | Depatuxizumab Biosimilar – Research Grade | 20mg |
| 3058 | ICH5294-50mg | Depatuxizumab Biosimilar – Research Grade | 50mg |
| 3059 | ICH5294-5mg | Depatuxizumab Biosimilar – Research Grade | 5mg |
| 3060 | ICH5294-1mg | Depatuxizumab Biosimilar – Research Grade | 1mg |
| 3061 | ICH5295-100mg | Pozelimab Biosimilar – Research Grade | 100mg |
| 3062 | ICH5295-10mg | Pozelimab Biosimilar – Research Grade | 10mg |
| 3063 | ICH5295-20mg | Pozelimab Biosimilar – Research Grade | 20mg |
| 3064 | ICH5295-50mg | Pozelimab Biosimilar – Research Grade | 50mg |
| 3065 | ICH5295-5mg | Pozelimab Biosimilar – Research Grade | 5mg |
| 3066 | ICH5295-1mg | Pozelimab Biosimilar – Research Grade | 1mg |
| 3067 | ICH5296-100mg | Retifanlimab Biosimilar – Research Grade | 100mg |
| 3068 | ICH5296-10mg | Retifanlimab Biosimilar – Research Grade | 10mg |
| 3069 | ICH5296-20mg | Retifanlimab Biosimilar – Research Grade | 20mg |
| 3070 | ICH5296-50mg | Retifanlimab Biosimilar – Research Grade | 50mg |
| 3071 | ICH5296-5mg | Retifanlimab Biosimilar – Research Grade | 5mg |
| 3072 | ICH5296-1mg | Retifanlimab Biosimilar – Research Grade | 1mg |
| 3073 | ICH5297-100mg | Ublituximab Biosimilar – Research Grade | 100mg |
| 3074 | ICH5297-10mg | Ublituximab Biosimilar – Research Grade | 10mg |
| 3075 | ICH5297-20mg | Ublituximab Biosimilar – Research Grade | 20mg |
| 3076 | ICH5297-50mg | Ublituximab Biosimilar – Research Grade | 50mg |
| 3077 | ICH5297-5mg | Ublituximab Biosimilar – Research Grade | 5mg |
| 3078 | ICH5297-1mg | Ublituximab Biosimilar – Research Grade | 1mg |
| 3079 | ICH5298-100mg | Loncastuximab Biosimilar – Research Grade | 100mg |
| 3080 | ICH5298-10mg | Loncastuximab Biosimilar – Research Grade | 10mg |
| 3081 | ICH5298-20mg | Loncastuximab Biosimilar – Research Grade | 20mg |
| 3082 | ICH5298-50mg | Loncastuximab Biosimilar – Research Grade | 50mg |
| 3083 | ICH5298-5mg | Loncastuximab Biosimilar – Research Grade | 5mg |
| 3084 | ICH5298-1mg | Loncastuximab Biosimilar – Research Grade | 1mg |
| 3085 | ICH5299-100mg | Ansuvimab Biosimilar – Research Grade | 100mg |
| 3086 | ICH5299-10mg | Ansuvimab Biosimilar – Research Grade | 10mg |
| 3087 | ICH5299-20mg | Ansuvimab Biosimilar – Research Grade | 20mg |
| 3088 | ICH5299-50mg | Ansuvimab Biosimilar – Research Grade | 50mg |
| 3089 | ICH5299-5mg | Ansuvimab Biosimilar – Research Grade | 5mg |
| 3090 | ICH5299-1mg | Ansuvimab Biosimilar – Research Grade | 1mg |
| 3091 | ICH5300-100mg | Crizanlizumab Biosimilar – Research Grade | 100mg |
| 3092 | ICH5300-10mg | Crizanlizumab Biosimilar – Research Grade | 10mg |
| 3093 | ICH5300-20mg | Crizanlizumab Biosimilar – Research Grade | 20mg |
| 3094 | ICH5300-50mg | Crizanlizumab Biosimilar – Research Grade | 50mg |
| 3095 | ICH5300-5mg | Crizanlizumab Biosimilar – Research Grade | 5mg |
| 3096 | ICH5300-1mg | Crizanlizumab Biosimilar – Research Grade | 1mg |
| 3097 | ICH5301-100mg | Moxetumomab Biosimilar – Research Grade | 100mg |
| 3098 | ICH5301-10mg | Moxetumomab Biosimilar – Research Grade | 10mg |
| 3099 | ICH5301-20mg | Moxetumomab Biosimilar – Research Grade | 20mg |
| 3100 | ICH5301-50mg | Moxetumomab Biosimilar – Research Grade | 50mg |
| 3101 | ICH5301-5mg | Moxetumomab Biosimilar – Research Grade | 5mg |
| 3102 | ICH5301-1mg | Moxetumomab Biosimilar – Research Grade | 1mg |
| 3103 | ICH5302-100mg | Lanadelumab Biosimilar – Research Grade | 100mg |
| 3104 | ICH5302-10mg | Lanadelumab Biosimilar – Research Grade | 10mg |
| 3105 | ICH5302-20mg | Lanadelumab Biosimilar – Research Grade | 20mg |
| 3106 | ICH5302-50mg | Lanadelumab Biosimilar – Research Grade | 50mg |
| 3107 | ICH5302-5mg | Lanadelumab Biosimilar – Research Grade | 5mg |
| 3108 | ICH5302-1mg | Lanadelumab Biosimilar – Research Grade | 1mg |
| 3109 | ICH5303-100mg | Tildrakizumab Biosimilar – Research Grade | 100mg |
| 3110 | ICH5303-10mg | Tildrakizumab Biosimilar – Research Grade | 10mg |
| 3111 | ICH5303-20mg | Tildrakizumab Biosimilar – Research Grade | 20mg |
| 3112 | ICH5303-50mg | Tildrakizumab Biosimilar – Research Grade | 50mg |
| 3113 | ICH5303-5mg | Tildrakizumab Biosimilar – Research Grade | 5mg |
| 3114 | ICH5303-1mg | Tildrakizumab Biosimilar – Research Grade | 1mg |
| 3115 | ICH5304-100mg | Bezlotoxumab Biosimilar – Research Grade | 100mg |
| 3116 | ICH5304-10mg | Bezlotoxumab Biosimilar – Research Grade | 10mg |
| 3117 | ICH5304-20mg | Bezlotoxumab Biosimilar – Research Grade | 20mg |
| 3118 | ICH5304-50mg | Bezlotoxumab Biosimilar – Research Grade | 50mg |
| 3119 | ICH5304-5mg | Bezlotoxumab Biosimilar – Research Grade | 5mg |
| 3120 | ICH5304-1mg | Bezlotoxumab Biosimilar – Research Grade | 1mg |
| 3121 | ICH5305-100mg | Olaratumab Biosimilar – Research Grade | 100mg |
| 3122 | ICH5305-10mg | Olaratumab Biosimilar – Research Grade | 10mg |
| 3123 | ICH5305-20mg | Olaratumab Biosimilar – Research Grade | 20mg |
| 3124 | ICH5305-50mg | Olaratumab Biosimilar – Research Grade | 50mg |
| 3125 | ICH5305-5mg | Olaratumab Biosimilar – Research Grade | 5mg |
| 3126 | ICH5305-1mg | Olaratumab Biosimilar – Research Grade | 1mg |
| 3127 | ICH5306-100mg | Obiltoxaximab Biosimilar – Research Grade | 100mg |
| 3128 | ICH5306-10mg | Obiltoxaximab Biosimilar – Research Grade | 10mg |
| 3129 | ICH5306-20mg | Obiltoxaximab Biosimilar – Research Grade | 20mg |
| 3130 | ICH5306-50mg | Obiltoxaximab Biosimilar – Research Grade | 50mg |
| 3131 | ICH5306-5mg | Obiltoxaximab Biosimilar – Research Grade | 5mg |
| 3132 | ICH5306-1mg | Obiltoxaximab Biosimilar – Research Grade | 1mg |
| 3133 | ICH5307-100mg | Idarucizumab Biosimilar – Research Grade | 100mg |
| 3134 | ICH5307-10mg | Idarucizumab Biosimilar – Research Grade | 10mg |
| 3135 | ICH5307-20mg | Idarucizumab Biosimilar – Research Grade | 20mg |
| 3136 | ICH5307-50mg | Idarucizumab Biosimilar – Research Grade | 50mg |
| 3137 | ICH5307-5mg | Idarucizumab Biosimilar – Research Grade | 5mg |
| 3138 | ICH5307-1mg | Idarucizumab Biosimilar – Research Grade | 1mg |
| 3139 | ICH5308-100mg | Dinutuximab Biosimilar – Research Grade | 100mg |
| 3140 | ICH5308-10mg | Dinutuximab Biosimilar – Research Grade | 10mg |
| 3141 | ICH5308-20mg | Dinutuximab Biosimilar – Research Grade | 20mg |
| 3142 | ICH5308-50mg | Dinutuximab Biosimilar – Research Grade | 50mg |
| 3143 | ICH5308-5mg | Dinutuximab Biosimilar – Research Grade | 5mg |
| 3144 | ICH5308-1mg | Dinutuximab Biosimilar – Research Grade | 1mg |
| 3145 | ICH5309-100mg | Certolizumab Biosimilar – Research Grade | 100mg |
| 3146 | ICH5309-10mg | Certolizumab Biosimilar – Research Grade | 10mg |
| 3147 | ICH5309-20mg | Certolizumab Biosimilar – Research Grade | 20mg |
| 3148 | ICH5309-50mg | Certolizumab Biosimilar – Research Grade | 50mg |
| 3149 | ICH5309-5mg | Certolizumab Biosimilar – Research Grade | 5mg |
| 3150 | ICH5309-1mg | Certolizumab Biosimilar – Research Grade | 1mg |
| 3151 | ICH5310-100mg | Ibritumomab Biosimilar – Research Grade | 100mg |
| 3152 | ICH5310-10mg | Ibritumomab Biosimilar – Research Grade | 10mg |
| 3153 | ICH5310-20mg | Ibritumomab Biosimilar – Research Grade | 20mg |
| 3154 | ICH5310-50mg | Ibritumomab Biosimilar – Research Grade | 50mg |
| 3155 | ICH5310-5mg | Ibritumomab Biosimilar – Research Grade | 5mg |
| 3156 | ICH5310-1mg | Ibritumomab Biosimilar – Research Grade | 1mg |
| 3157 | ICH5311-100mg | Dostarlimab Biosimilar – Research Grade | 100mg |
| 3158 | ICH5311-10mg | Dostarlimab Biosimilar – Research Grade | 10mg |
| 3159 | ICH5311-20mg | Dostarlimab Biosimilar – Research Grade | 20mg |
| 3160 | ICH5311-50mg | Dostarlimab Biosimilar – Research Grade | 50mg |
| 3161 | ICH5311-5mg | Dostarlimab Biosimilar – Research Grade | 5mg |
| 3162 | ICH5311-1mg | Dostarlimab Biosimilar – Research Grade | 1mg |
| 3163 | ICH5312-100mg | Golimumab Biosimilar – Research Grade | 100mg |
| 3164 | ICH5312-10mg | Golimumab Biosimilar – Research Grade | 10mg |
| 3165 | ICH5312-20mg | Golimumab Biosimilar – Research Grade | 20mg |
| 3166 | ICH5312-50mg | Golimumab Biosimilar – Research Grade | 50mg |
| 3167 | ICH5312-5mg | Golimumab Biosimilar – Research Grade | 5mg |
| 3168 | ICH5312-1mg | Golimumab Biosimilar – Research Grade | 1mg |
| 3169 | ICH5313-100mg | Benralizumab Biosimilar – Research Grade | 100mg |
| 3170 | ICH5313-10mg | Benralizumab Biosimilar – Research Grade | 10mg |
| 3171 | ICH5313-20mg | Benralizumab Biosimilar – Research Grade | 20mg |
| 3172 | ICH5313-50mg | Benralizumab Biosimilar – Research Grade | 50mg |
| 3173 | ICH5313-5mg | Benralizumab Biosimilar – Research Grade | 5mg |
| 3174 | ICH5313-1mg | Benralizumab Biosimilar – Research Grade | 1mg |
| 3175 | ICH5314-100mg | Ocrelizumab Biosimilar – Research Grade | 100mg |
| 3176 | ICH5314-10mg | Ocrelizumab Biosimilar – Research Grade | 10mg |
| 3177 | ICH5314-20mg | Ocrelizumab Biosimilar – Research Grade | 20mg |
| 3178 | ICH5314-50mg | Ocrelizumab Biosimilar – Research Grade | 50mg |
| 3179 | ICH5314-5mg | Ocrelizumab Biosimilar – Research Grade | 5mg |
| 3180 | ICH5314-1mg | Ocrelizumab Biosimilar – Research Grade | 1mg |
| 3181 | ICH5315-100mg | Telisotuzumab Biosimilar – Research Grade | 100mg |
| 3182 | ICH5315-10mg | Telisotuzumab Biosimilar – Research Grade | 10mg |
| 3183 | ICH5315-20mg | Telisotuzumab Biosimilar – Research Grade | 20mg |
| 3184 | ICH5315-50mg | Telisotuzumab Biosimilar – Research Grade | 50mg |
| 3185 | ICH5315-5mg | Telisotuzumab Biosimilar – Research Grade | 5mg |
| 3186 | ICH5315-1mg | Telisotuzumab Biosimilar – Research Grade | 1mg |